Devices › Device types
FDA product code PJE · class 2 · Clinical Chemistry
Blood/plasma collection device for dna testing: medical device reports filed with FDA
585 reports carry this product code, 2018–2026; 4 brands with a page.
- 585
- reports with this product code
- 0% of all MAUDE reports
- 54
- reports, 12 months to August 2026
- 372 in the 12 months before
- 100%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code PJE is FDA's classification for "Blood/plasma collection device for dna testing" (clinical Chemistry panel), a class 2 device. 585 medical device reports carry this product code, 0% of the MAUDE database, from May 2018 to August 2026.
54 reports arrived in the 12 months to August 2026, down 85% from 372 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (100%). 4 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| BD Vacutainer PPT Plasma Preparation Tube K2E 9.0 mg | 257 | 56 | 0% | 100% |
| Bd Vacutainer Ppt Plasma Preparation Tubes K2e Edta 9 0 Mg | 150 | 1 | 0% | 100% |
| Bd Vacutainer 9nc 0 129m Plus Blood Collection Tubes | 1 | 12 | 0% | 100% |
| Bd Vacutainer Eclipse Signal Blood Collection Needle | 1 | 8 | 0% | 98.1% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Becton Dickinson & Broken Bow | 489 | 83.6% |
| Becton Dickinson And Bd | 53 | 9.1% |
| Becton Dickinson & Franklin Lakes | 21 | 3.6% |
| Bd Suzhou | 3 | 0.5% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Incorrect, inadequate or imprecise result or readings | 250 | 42.7% |
| Device ingredient or reagent problem | 148 | 25.3% |
| Device contamination with chemical or other material | 77 | 13.2% |
| Short fill | 35 | 6% |
| Device markings/labelling problema problem with the device markings or label | 22 | 3.8% |
| Leak/splashthe device leaked | 13 | 2.2% |
| Incorrect or inadequate test results | 9 | 1.5% |
| Volume accuracy problem | 9 | 1.5% |
| Material deformation | 6 | 1% |
| Material discolored | 5 | 0.9% |
| Coagulation in device or device ingredient | 4 | 0.7% |
| Fluid/blood leak | 4 | 0.7% |
| Particulates | 4 | 0.7% |
| Fracturea broken bone | 3 | 0.5% |
| Improper chemical reaction | 3 | 0.5% |
| Breakthe device broke | 2 | 0.3% |
| Component missing | 2 | 0.3% |
| Crackthe device cracked | 2 | 0.3% |
| Improper or incorrect procedure or method | 2 | 0.3% |
| Inaccurate information | 2 | 0.3% |
Questions about blood/plasma collection device for dna testing reports
What is product code PJE?
FDA's classification code for "Blood/plasma collection device for dna testing", class 2, reviewed by the clinical Chemistry panel. Every device report carries the product code of the device involved.
How many reports carry this code?
585 reports through August 2026, 54 of them in the latest 12 months.
Which brands appear most often?
BD Vacutainer PPT Plasma Preparation Tube K2E 9.0 mg (257), Bd Vacutainer Ppt Plasma Preparation Tubes K2e Edta 9 0 Mg (150), Bd Vacutainer 9nc 0 129m Plus Blood Collection Tubes (1) and Bd Vacutainer Eclipse Signal Blood Collection Needle (1). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.